Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Cancer Research Communications
|
February 27, 2023
Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 (HDAC3) Stabilization and Chromatin Condensation
Laure Maneix, Polina Iakova, Shannon E Moree, et al.
Transplantation and Cellular Therapy
|
September 14, 2024
Efficacy of Letermovir for Cytomegalovirus Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant
Ibrahim N Muhsen, Kristen E Shaver, Tao Wang, et al.
Haematologica
|
April 21, 2019
Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections
Spyridoula Vasileiou, Anne M Turney, Manik Kuvalekar, et al.
The Journal of Infectious Diseases
|
May 5, 2017
Characterizing the Cellular Immune Response to Parainfluenza Virus 3
Paibel I Aguayo-Hiraldo, Reuben J Arasaratnam, Ifigeneia Tzannou, et al.
Leukemia & Lymphoma
|
July 19, 2021
Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study
Samer Al Hadidi, Deepa Dongarwar, Hamisu M Salihu, et al.
The Journal of Infectious Diseases
|
September 22, 2017
Immunologic Profiling of Human Metapneumovirus for the Development of Targeted Immunotherapy
Ifigeneia Tzannou, Sarah K Nicholas, Premal Lulla, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 5, 2018
CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia
Diogo Gomes-Silva, Erden Atilla, Pinar Ataca Atilla, et al.
Blood
|
January 19, 2024
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia
Wingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim, et al.
Blood
|
January 10, 2024
The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature
Anna Mathioudaki, Xizhe Wang, David Sedloev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 11, 2023
Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting
Thomas Pfeiffer, Ifigeneia Tzannou, Mengfen Wu, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Cancer Research Communications
|
February 27, 2023
Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 (HDAC3) Stabilization and Chromatin Condensation
Laure Maneix, Polina Iakova, Shannon E Moree, et al.
Transplantation and Cellular Therapy
|
September 14, 2024
Efficacy of Letermovir for Cytomegalovirus Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant
Ibrahim N Muhsen, Kristen E Shaver, Tao Wang, et al.
Haematologica
|
April 21, 2019
Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections
Spyridoula Vasileiou, Anne M Turney, Manik Kuvalekar, et al.
The Journal of Infectious Diseases
|
May 5, 2017
Characterizing the Cellular Immune Response to Parainfluenza Virus 3
Paibel I Aguayo-Hiraldo, Reuben J Arasaratnam, Ifigeneia Tzannou, et al.
Leukemia & Lymphoma
|
July 19, 2021
Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study
Samer Al Hadidi, Deepa Dongarwar, Hamisu M Salihu, et al.
The Journal of Infectious Diseases
|
September 22, 2017
Immunologic Profiling of Human Metapneumovirus for the Development of Targeted Immunotherapy
Ifigeneia Tzannou, Sarah K Nicholas, Premal Lulla, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 5, 2018
CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia
Diogo Gomes-Silva, Erden Atilla, Pinar Ataca Atilla, et al.
Blood
|
January 19, 2024
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia
Wingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim, et al.
Blood
|
January 10, 2024
The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature
Anna Mathioudaki, Xizhe Wang, David Sedloev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 11, 2023
Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting
Thomas Pfeiffer, Ifigeneia Tzannou, Mengfen Wu, et al.
Page
of 4